Hanrahan Jessie — SEC Form 4 filings
SEC reporting owner CIK 1954826. 10 Form 4 filings on record with FilingPulse; latest filed 2026-04-21.
Transaction summary — filings shown
Covers all 10 filings on record, filed 2024-02-16 to 2026-04-21. Counts and totals are arithmetic on values as filed — descriptive data, not a recommendation.
- Open-market purchases (code P, non-derivative): none reported.
- Open-market sales (code S, non-derivative): 6 legs across 6 filings — 55,189 shares, $335,345 total (shares × price as filed).
- Other reported legs (grants, option exercises, tax withholding, gifts, derivative-security transactions, …): 20.
- Largest priced transaction: sale of 26,535 shares @ $6.44 ($170,803) in Solid Biosciences Inc., filed 2026-02-02.
By issuer — same filings
Open-market purchase/sale legs on non-derivative securities, grouped by issuer. Role is as filed on the newest filing for that issuer. Dollar totals cover priced legs only (shares × price as filed). Ordered by priced transaction value, largest first.
| Issuer | Role (as filed) | Filings | Purchases (P) | Sales (S) | Other legs |
|---|---|---|---|---|---|
| Solid Biosciences Inc. (SLDB) | Chief Regulatory Officer | 10 | — | 6 legs · 55,189 sh · $335,345 | 20 |
Form 4 filings — Hanrahan Jessie
| Filed | Form | Issuer | Reported transactions | Source |
|---|---|---|---|---|
| 2026-04-21 | 4 | Solid Biosciences Inc. (SLDB) | Grant/award (A): 54,925 (derivative) @ $0 | EDGAR |
| 2026-02-18 | 4 | Solid Biosciences Inc. (SLDB) | Option exercise (M): 8,125 · Sale (S): 4,134 @ $5.82 · Option exercise (M): 8,125 (derivative) @ $0 | EDGAR |
| 2026-02-06 | 4 | Solid Biosciences Inc. (SLDB) | Sale (S): 12,348 @ $6.44 | EDGAR |
| 2026-02-02 | 4 | Solid Biosciences Inc. (SLDB) | Option exercise (M): 54,925 · Option exercise (M): 27,625 · Sale (S): 26,535 @ $6.44 · Option exercise (M): 54,925 (derivative) @ $0 · Grant/award (A): 190,000 (derivative) @ $0 · Grant/award (A): 95,000 (derivative) @ $0 · +1 more | EDGAR |
| 2025-12-04 | 4 | Solid Biosciences Inc. (SLDB) | Option exercise (M): 11,862 · Sale (S): 4,483 @ $5.11 · Option exercise (M): 11,862 (derivative) @ $0 | EDGAR |
| 2025-08-18 | 4 | Solid Biosciences Inc. (SLDB) | Grant/award (A): 142,500 (derivative) @ $0 · Grant/award (A): 71,250 (derivative) @ $0 | EDGAR |
| 2025-02-18 | 4 | Solid Biosciences Inc. (SLDB) | Option exercise (M): 8,125 · Sale (S): 3,079 @ $3.96 · Option exercise (M): 8,125 (derivative) @ $0 | EDGAR |
| 2025-02-11 | 4 | Solid Biosciences Inc. (SLDB) | Grant/award (A): 110,500 (derivative) @ $0 | EDGAR |
| 2024-12-04 | 4 | Solid Biosciences Inc. (SLDB) | Option exercise (M): 11,862 · Sale (S): 4,610 @ $5.60 · Option exercise (M): 11,862 (derivative) @ $0 | EDGAR |
| 2024-02-16 | 4 | Solid Biosciences Inc. (SLDB) | Grant/award (A): 65,000 (derivative) @ $0 · Grant/award (A): 32,500 (derivative) @ $0 | EDGAR |
FilingPulse's Form 4 archive currently extends back to 2024-01-11 and is expanding backward through EDGAR history — earlier filings by this insider may not be indexed yet. Names and roles are shown as filed.
Need this as JSON?
GET https://api.filingpulse.io/v1/insider-trades?owner_cik=1954826 returns every filing on this page — normalized, with footnotes and derivative legs — and webhooks push new filings to you in seconds. API docs →